First Trust Advisors’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.3M | Buy |
113,907
+32,221
| +39% | +$1.78M | 0.01% | 1258 |
|
|
2025
Q1 | $3.95M | Sell |
81,686
-59,265
| -42% | -$2.87M | ﹤0.01% | 1432 |
|
|
2024
Q4 | $5.44M | Buy |
140,951
+27
| +0% | +$1.04K | ﹤0.01% | 1315 |
|
|
2024
Q3 | $6.34M | Buy |
140,924
+9,114
| +7% | +$410K | 0.01% | 1218 |
|
|
2024
Q2 | $4.57M | Buy |
131,810
+71,147
| +117% | +$2.47M | ﹤0.01% | 1307 |
|
|
2024
Q1 | $1.75M | Buy |
+60,663
| New | +$1.75M | ﹤0.01% | 1791 |
|
|
2022
Q3 | – | Sell |
-14,328
| Closed | -$113K | – | 2583 |
|
|
2022
Q2 | $113K | Sell |
14,328
-27,444
| -66% | -$216K | ﹤0.01% | 2450 |
|
|
2022
Q1 | $989K | Buy |
+41,772
| New | +$989K | ﹤0.01% | 2047 |
|